Why the study?
Is the alpha-adducin 460 polymorphism associated with an increased risk of essential hypertension in a Japanese population?
Is the alpha-adducin 460 polymorphism associated with an increased risk of essential hypertension in a Japanese population?
The alpha-adducin 460 polymorphism is not a major genetic risk factor for essential hypertension in the Japanese population, contrasting with previous findings in white populations.
Answers are grounded in this paper and cite their sources.
Alpha-adducin polymorphism should not guide hypertension risk assessment in Japanese patients; challenges prior associations reported in white populations.
Many unknown genetic factors are involved in the pathogenesis of hypertension. Recently, the reverse genetic approach revealed that some genetic variants, such as angiotensinogen, lipoprotein lipase, and alpha-adducin gene polymorphisms, increase the risk for hypertension. Both in rat and human, the genetic predisposition to hypertension was confirmed only for angiotensinogen and alpha-adducin genes. Adducin is a membrane cytoskeletal protein, which is thought to regulate sodium transport. Abnormalities of membrane sodium transport in the kidney play an important role in hypertension. A recent report by Cusi et al showed that the Trp allele of alpha-adducin polymorphism (Gly 460 Trp) is associated with an increased risk of hypertension in whites, which led us to carry out a case-control study to examine whether the same association is observed in the Japanese population. We recruited 170 hypertensive and 194 normotensive Japanese subjects and compared the genotype distribution of alpha-adducin 460 polymorphism between cases and controls and between whites and Japanese. Trp allele frequency of controls in the Japanese subjects was twice as high as in the whites. However, no association was observed between alpha-adducin polymorphism and hypertension. Furthermore, alpha-adducin 460 polymorphism was not associated with any clinical characteristics. Accordingly, we concluded that alpha-adducin 460 polymorphism is not a major genetic risk for hypertension in Japanese people.
No takes yet. Share an insight, caveat, or question.
Katsunori ISHIKAWA (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: